Disease X Partners Stakeholder Mapping and Landscaping

About CEPI
Launched in 2017, the Coalition for Epidemic Preparedness Innovations (CEPI) is an international coalition of governments, academic, philanthropic, private, public, and intergovernmental institutions whose vision is to create a world in which epidemics and pandemics are no longer a threat to humanity. Our mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. CEPI has overseen a number of scientific “firsts”, including the first-ever Chikungunya vaccine to receive approval, the advancement of the first-ever Nipah virus vaccines into Phase 1 trials, and a MERS and Lassa vaccine into first-ever Phase 2 trials. CEPI has also supported the development of four COVID-19 vaccines, which have received WHO Emergency Use Listing (EUL), and co-lead COVAX, the global initiative to support equitable access to COVID-19 vaccines CEPI’s five-year plan for 2022-2026 – known as CEPI 2.0 - aims to dramatically reduce or even eliminate the future risk of pandemics and epidemics. Central to the plan is CEPI’s goal to accelerate the time taken to develop safe, effective, globally accessible vaccines against new threats to just 100 days. Achieving this ‘100 Days Mission’, which has been embraced by leaders of the G7 and G20, would give the world a fighting chance of containing a future outbreak before it can spread to become a global pandemic, potentially averting millions of deaths and trillions of dollars in economic damage. CEPI is a not-for-profit association under Norwegian Law and has offices in Oslo (HQ), London, and Washington DC. In CEPI we strive for diverse thinking, and we want a diverse pool of candidates for all our vacancies. We work for an inclusive working environment where each employee can contribute and grow. More details about CEPI and our mission can be found on our website: www.cepi.net
About the Tender
CEPI is seeking to identify new opportunities or gaps in our portfolio of partners in order to enable a more effective Disease X response. To that end, we are seeking to perform current and prospective stakeholder mapping and perform landscaping in key areas along the Disease X value chain that would support CEPI’s 100 Day Mission. To support this work along with the activities of the wider organisation, we are seeking the consultancy services from experts with a combination of experiences in the following areas:
- Pandemic Preparedness and Response
- Virology, Vaccinology, Infectious Disease and/or Immunology
- Global Health & Medicine
- Strategic Consulting
- Landscaping and Deep Scientific Research
- Pharmaceutical/Vaccine/Biotech macro trends
Activities under the project might include some or all of the following:
- Alignment with CEPI on definitions, key deliverables and partner requirements
- Evaluation of CEPI’s current Disease X portfolio, including process/gap analysis and stakeholder mapping
- Information gathering from subject matter experts within and outside of CEPI via interviews, workshops or exercises.
- Landscaping of key areas using proprietary and public databases, ideally AI/ML enabled with manual review/curation.
- In-depth profiling of companies of particular interest, potentially including interviews or other active data gathering
- Delivery of landscape datasets, company profiles and report/presentations of key insights and recommendations.
Further details and How to Apply
Please download the Request for Proposals document for further information and details on eligibility and review criteria. The deadline for proposals is the 1st of July 2025 (23:59:59 GMT) If you have any questions, please contact Mats Olsen (mats.olsen@cepi.net)